VOR BIOPHARMA INC. - C

Vor Bio Announces $175 Million Private Placement

25 6月 2025 13:50:16 条件 Nasdaq GlobeNewswire

Vor Bio Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset

25 6月 2025 13:45:03 条件 Nasdaq GlobeNewswire

Vor Bio Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

08 5月 2025 05:30:15 条件 Nasdaq GlobeNewswire

Vor Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update

20 3月 2025 13:05:00 条件 Nasdaq GlobeNewswire

Vor Bio Presents Novel Research Highlighting Opportunities and Challenges Facing Institutions Enrolling Patients in Cell and Gene Therapy Trials

13 2月 2025 05:00:00 条件 Nasdaq GlobeNewswire

Vor Bio to Participate in the Oppenheimer's 35th Annual Healthcare Life Sciences Conference

03 2月 2025 05:00:00 条件 Nasdaq GlobeNewswire

Vor Bio Appoints Life Sciences and Technology Investor and Entrepreneur, Mr. Erez Kalir to its Board of Directors

08 1月 2025 06:00:00 条件 Nasdaq GlobeNewswire

Vor Bio Announces $55.6 Million Private Placement

27 12月 2024 06:00:15 条件 Nasdaq GlobeNewswire

Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design

09 12月 2024 04:30:00 条件 Nasdaq GlobeNewswire

Vor Bio to Participate in the Stifel 2024 Healthcare Conference

12 11月 2024 05:00:02 条件 Nasdaq GlobeNewswire

Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company Update

07 11月 2024 13:05:01 条件 Nasdaq GlobeNewswire

Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer

30 9月 2024 04:00:00 条件 Nasdaq GlobeNewswire

New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies

05 9月 2024 13:01:00 条件 Nasdaq GlobeNewswire

Vor Bio to Participate in Upcoming Investor Conferences

28 8月 2024 05:00:00 条件 Nasdaq GlobeNewswire

Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update

08 8月 2024 13:05:02 条件 Nasdaq GlobeNewswire

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

02 8月 2024 13:01:00 条件 Nasdaq GlobeNewswire

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

09 7月 2024 13:01:00 条件 Nasdaq GlobeNewswire

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

04 6月 2024 13:01:00 条件 Nasdaq GlobeNewswire

Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update

09 5月 2024 13:05:00 条件 Nasdaq GlobeNewswire

Vor Bio to Participate in Upcoming Investor Conferences

06 5月 2024 05:00:00 条件 Nasdaq GlobeNewswire